Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Up 45.4% in February

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 13th, there was short interest totaling 15,855 shares, a growth of 45.4% from the January 29th total of 10,905 shares. Based on an average daily volume of 14,132 shares, the short-interest ratio is presently 1.1 days. Approximately 1.0% of the shares of the stock are sold short. Approximately 1.0% of the shares of the stock are sold short. Based on an average daily volume of 14,132 shares, the short-interest ratio is presently 1.1 days.

Arcadia Biosciences Stock Performance

NASDAQ RKDA traded down $0.02 during trading hours on Friday, reaching $1.95. The company’s stock had a trading volume of 5,987 shares, compared to its average volume of 14,773. The company’s 50-day moving average is $2.18 and its two-hundred day moving average is $3.22. Arcadia Biosciences has a fifty-two week low of $1.54 and a fifty-two week high of $6.71. The stock has a market cap of $3.38 million, a PE ratio of 0.77 and a beta of 0.60.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arcadia Biosciences in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

View Our Latest Analysis on Arcadia Biosciences

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.